CD274 and breast cancer: Regardless, pharmacological manipulation of the immune regulatory effect of acetylcholinergic signaling, alone or in combination with immune checkpoint inhibitors, e.g., anti-PD1/PD-L1 antibodies, is potentially useful for the treatment of BC and other types of cancers.